|
Introductie OncoNeth Partners |
|
OncoNeth Partners is gespecialiseerd in Pre-Marketing en In-line activiteiten voor Oncologische middelen. Wij adviseren bedrijven op het terrein van Strategie, Prijs & Vergoeding en werken samen met een uitgebreid netwerk van specialisten. Voor meer informatie verwijzen wij u naar: www.onconethpartners.com. |
|
|
Dutch reimbursement for expensive hospital treatments |
|
Monday, 06 July 2009 00:00 |
|
With the availability of targeted and expensive hospital treatments for e.g. cancer and rheumatoid arthritis, a new funding system was introduced in 2006 in order to refund Dutch hospitals. This policy measure allows new therapies to be applied in hospital quickly following registration with a mandatory research requirement for cost-effectiveness in daily practice. We offer a short training on the specifics of this policy and what it can mean for your new product. Please contact us for further information. |
|
|
Pharmaco-economics in Dutch decision-making |
|
Monday, 06 July 2009 00:00 |
|
Dutch health-care decision-making increasingly incorporates cost-effectiveness as an explicit factor, both at the national policy level as by healthcare insurance companies and in the development of professional treatment guidelines. We have a good overview of current requirements and future directions to guide our clients to successful market access for their products. Contact us for further information.
|
|
|
|
|
|
